• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NAVIGATION, INC MEDTRONIC NAVIGATION; NEUROLOGICAL STEREOTAXIC INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NAVIGATION, INC MEDTRONIC NAVIGATION; NEUROLOGICAL STEREOTAXIC INSTRUMENT Back to Search Results
Model Number UNK_NAV_SYS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Hemorrhage/Bleeding (1888); Dysphasia (2195); Unspecified Tissue Injury (4559); Insufficient Information (4580)
Event Date 01/06/2022
Event Type  Injury  
Manufacturer Narrative
Stealthstation dbs targeting software and stealth station cranial software were used in the procedures.Specific product information is unavailable.H3, h6: no products have been returned to medtronic for analysis.Codes b17, c20, and d15 are applicable.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Citation: doi: 10.1227/ons.0000000000000059 summary: background: methodological approaches to deep brain stimulation (dbs) continue to evolve from awake frame-based to asleep frameless procedures with robotic assistance, primarily directed to optimize operative efficiency, lead accuracy, and patient comfort.Comparison between the 2 is scarce.Objective: to analyze the impacts of methodological differences on operative efficiency and stereotactic accuracy using a frame compared with a frameless robotic platform while maintaining the awake state and use of multiple microelectrode recording (mer) trajectories.Methods: thirty-four consecutive patients who underwent bilateral awake frameless robot-assisted dbs were compared with a previous cohort of 30 patients who underwent frame-based surgery.Patient demographics, operative times, and mer data were collected for both cohorts.Two-dimensional radial errors of lead placements were calculated.Results: preoperative setup, surgical, and total operating room times were all significantly greater for the robot-assisted cohort (p <.001).The need for computed tomography imaging when referencing the robotic fiducials led to increased setup duration because of patient transport, unnecessary for the frame-based cohort.Multiple simultaneous mer trajectories increased surgical time (mean 26 min) for the robot-assisted cohort only.The mean radial errors in the robot-assisted and frame cohorts were 0.98 ± 0.66 and 0.74 ± 0.49 mm (p =.03), respectively.Conclusion: the use of a truly frameless robotic platform such as the mazor renaissance (mazor robotics ltd) presented challenges when implementing techniques used during awake frame-based surgery.Maintaining good accuracy, intraoperative reference imaging, and limited mer trajectories will help integrate frameless robot assistance into the awake dbs surgical workflow.Reported events: in the robotic-assisted cohort, there were 28 surgeries that were examined retrospectively for this study, 17 male patients and 11 female patients.In the frame cohort, there were 20 patients, 29 male and 9 female.In the robot-assisted cohort, there was a small track intraparenchymal hemorrhage that caused transient facial drooping and dysarthria intraoperatively, which was fully resolved by the 2-week postoperative visit.One patient developed an erosion over his right frontal incision leading to exposure of the electrode at postoperative day 40, which subsequently led to complete explantation of the system and a course of antibiotics (1/28 hemorrhage, 1/28 erosion/infection).There were no erosions, infections, or hemorrhages during the follow-up period.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC NAVIGATION
Type of Device
NEUROLOGICAL STEREOTAXIC INSTRUMENT
Manufacturer (Section D)
MEDTRONIC NAVIGATION, INC
826 coal creek circle
louisville CO 80027
Manufacturer (Section G)
MEDTRONIC NAVIGATION, INC
826 coal creek circle
louisville CO 80027
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key18971328
MDR Text Key338554106
Report Number1723170-2024-00891
Device Sequence Number1
Product Code HAW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 03/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK_NAV_SYS
Device Catalogue NumberUNK_NAV_SYS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/04/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-